Ricoh USA, recognized for its custom medical device design expertise through Ricoh 3D for Healthcare, has joined forces with SimBioSys, a technology company specializing in AI and computational modeling. Together, they are exploring innovative ways to improve breast cancer treatment through the integration of artificial intelligence and advanced 3D printing. Their goal is to create patient-specific breast cancer models that can enhance surgical procedures and personalize patient care, potentially revolutionizing the way breast cancer is treated and managed.
This collaboration between Ricoh and SimBioSys combines SimBioSys’ AI capabilities with Ricoh’s 3D printing expertise to develop accurate, individualized models for breast cancer treatment. The partnership aims to improve surgical planning and provide patients and surgeons with better insights into complex cancer surgeries before the first incision.
The companies recently showcased their advancements at the American Society of Breast Surgeons conference in April 2024, where they presented their innovative breast cancer models to attendees. Gary Turner, Managing Director at Ricoh USA, emphasized the importance of this collaboration in redefining the future of medical treatment. While the partnership’s workflow is currently for educational purposes and not approved for diagnostic use, it marks a significant step toward the future clinical application of AI and 3D printing in personalized breast cancer care.
Subscribe to AM Chronicle Newsletter to stay connected: https://bit.ly/3fBZ1mP
Follow us on LinkedIn: https://bit.ly/3IjhrFq
Visit for more interesting content on additive manufacturing: https://amchronicle.com
